• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌脑转移的治疗。

Treatment of breast cancer brain metastases.

作者信息

Hofer Silvia, Pestalozzi Bernhard C

机构信息

Department of Oncology, University Hospital, Raemistrasse 100, 8091 Zürich, Switzerland.

出版信息

Eur J Pharmacol. 2013 Oct 5;717(1-3):84-7. doi: 10.1016/j.ejphar.2012.11.068. Epub 2013 Mar 30.

DOI:10.1016/j.ejphar.2012.11.068
PMID:23545362
Abstract

Breast cancer represents the second most frequent cause of brain metastases. Treatment planning should consider several tumor and patient factors to estimate prognosis based on the Karnofsky Performance Status (KPS), age, extent of extra-cerebral disease as well as genetic subtype. When systemic disease is under control patients with up to three metastases qualify for local therapy, such as surgical excision or stereotactic radiotherapy. After the local treatment the addition of whole brain radiation therapy may be postponed until disease progression in the brain is observed and overall survival will not be compromised. Asymptomatic brain metastases may be first approached with a systemic treatment to which the primary tumor is considered to be sensitive.

摘要

乳腺癌是脑转移的第二大常见病因。治疗方案的制定应综合考虑多种肿瘤和患者因素,以根据卡氏功能状态评分(KPS)、年龄、脑外疾病范围以及基因亚型来评估预后。当全身疾病得到控制时,脑转移灶不超过三个的患者适合接受局部治疗,如手术切除或立体定向放射治疗。局部治疗后,全脑放疗可推迟至观察到脑部疾病进展且不影响总生存期时进行。无症状脑转移可首先采用对原发肿瘤敏感的全身治疗。

相似文献

1
Treatment of breast cancer brain metastases.乳腺癌脑转移的治疗。
Eur J Pharmacol. 2013 Oct 5;717(1-3):84-7. doi: 10.1016/j.ejphar.2012.11.068. Epub 2013 Mar 30.
2
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.乳腺癌脑转移患者行放射外科治疗中外周疾病状态和肿瘤亚型的重要性。
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e479-86. doi: 10.1016/j.ijrobp.2012.01.054.
3
Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.乳腺癌脑转移患者两种全脑放疗方案及预后因素的评估。
Cancer. 2007 Dec 1;110(11):2587-92. doi: 10.1002/cncr.23082.
4
[Brain metastases and their treatment].[脑转移瘤及其治疗]
Rev Prat. 1996 Feb 15;46(4):457-63.
5
Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.立体定向放射外科治疗单发性脑转移瘤患者的预后因素分析。
Radiat Oncol Investig. 1997;5(1):31-7. doi: 10.1002/(SICI)1520-6823(1997)5:1<31::AID-ROI5>3.0.CO;2-L.
6
Management of brain metastases.脑转移瘤的管理
J Neurol. 2002 Oct;249(10):1357-69. doi: 10.1007/s00415-002-0870-6.
7
[Brain metastases from breast cancer].[乳腺癌脑转移]
Cancer Radiother. 2013 Nov;17(7):708-14. doi: 10.1016/j.canrad.2013.09.002. Epub 2013 Nov 5.
8
Radiation therapy for brain metastases in breast cancer patients.乳腺癌脑转移患者的放射治疗。
Breast Cancer. 2011 Oct;18(4):244-51. doi: 10.1007/s12282-010-0207-8. Epub 2010 May 11.
9
Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.递归分割分析(RPA)分类法无法预测有四个或更多脑转移瘤患者的生存率。
Strahlenther Onkol. 2003 Jan;179(1):16-20. doi: 10.1007/s00066-003-1028-x.
10
[Cerebral metastatis. Diagnostic and therapeutic features].[脑转移瘤。诊断与治疗特点]
Recenti Prog Med. 2000 Jun;91(6):327-31.

引用本文的文献

1
SEOM clinical guidelines in advanced and recurrent breast cancer (2018).SEOM 临床指南:晚期和复发性乳腺癌(2018 年)。
Clin Transl Oncol. 2019 Jan;21(1):31-45. doi: 10.1007/s12094-018-02010-w. Epub 2019 Jan 8.
2
Apparent diffusion coefficient histogram in breast cancer brain metastases may predict their biological subtype and progression.乳腺癌脑转移的表观扩散系数直方图可预测其生物学亚型和进展。
Sci Rep. 2018 Jul 2;8(1):9947. doi: 10.1038/s41598-018-28315-y.
3
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
乳腺癌亚型和分期是从乳腺癌诊断到脑转移发展时间的预后因素。
J Neurooncol. 2017 Sep;134(2):453-463. doi: 10.1007/s11060-017-2549-y. Epub 2017 Jul 3.
4
SEOM clinical guidelines in metastatic breast cancer 2015.2015年SEOM转移性乳腺癌临床指南
Clin Transl Oncol. 2015 Dec;17(12):946-55. doi: 10.1007/s12094-015-1476-7. Epub 2015 Dec 18.
5
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.乳腺癌亚型作为立体定向放射外科治疗脑转移瘤的预后和控制预测指标。
J Neurooncol. 2016 Mar;127(1):103-10. doi: 10.1007/s11060-015-2014-8. Epub 2015 Nov 28.
6
NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.NKTR-102与伊立替康在乳腺癌脑转移小鼠模型中的疗效对比
BMC Cancer. 2015 Oct 13;15:685. doi: 10.1186/s12885-015-1672-4.
7
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.改良版乳腺癌分级预后评估作为乳腺癌合并脑转移患者生存工具的验证与开发
J Clin Oncol. 2015 Jul 10;33(20):2239-45. doi: 10.1200/JCO.2014.58.8517. Epub 2015 May 18.
8
Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes.脑转移瘤的局部控制:与亚型相关的局灶性脑部治疗的治疗结果。
J Breast Cancer. 2015 Mar;18(1):29-35. doi: 10.4048/jbc.2015.18.1.29. Epub 2015 Mar 27.